Effects of the PARP Inhibitor Olaparib on the Response of Human Peripheral Blood Leukocytes to Bacterial Challenge or Oxidative Stress
Sidnéia Sousa Santos(Universidade Federal de São Paulo), Reinaldo Salomão(Universidade Federal de São Paulo)
Cited by 23
Related Papers
A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19
|JCI Insight|2025|21
Evaluation of Toll-like, chemokine, and integrin receptors on monocytes and neutrophils from peripheral blood of septic patients and their correlation with clinical outcomes
|Brazilian Journal of Medical and Biological Research|2014|17